Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

100 µg Brimonidine Tartrate Implant

[1] Brimonidine (Brimonidine Tartrate)

[1] Brimonidine 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 90 💬

2

200 µg Brimonidine Tartrate Implant

[1] Brimonidine (Brimonidine Tartrate)

[1] Brimonidine 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 90 💬

3

400 µg Brimonidine Tartrate Implant

[1] Brimonidine (Brimonidine Tartrate)

[1] Brimonidine 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 90 💬

4

Brimonidine tartrate

[1] Brimonidine (Brimonidine Tartrate)

[1] Brimonidine 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[2] 13, 90 💬

5

Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System

[1] Brimonidine (Brimonidine Tartrate)

[1] Brimonidine 💬

[3] ADRA2A,
ADRA2B,
ADRA2C 💬

[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬

[1] 90 💬